Deepak Nitrite Ltd

Deepak Nitrite FY26: Revenue at ₹7,947 Cr, Major Capex & Capacity Expansion Drive 🏭📈

- Deepak Nitrite Limited (DNL) will hold its 55th Annual General Meeting (AGM) on Wednesday, August 5, 2026 at 11:30 A.M. (IST) through Video Conferencing/Other Audio Visual Means.

- The company has published its 55th Annual Integrated Report for the Financial Year 2025-26, which includes the notice for the AGM.

- Key financial highlights for FY 2025-26 include revenues of ₹ 7,947 Crores and a net worth of ₹ 5,837 Crores.

- A dividend of ₹ 7.50 per share was declared for FY 2025-26, amounting to a total dividend payout of ₹ 102 Crores.

- The company's manufacturing infrastructure includes 7 modern facilities across 5 strategic locations in India.

- Key operational milestones include the commissioning of a Nitric Acid plant at Nandesari and nitration and hydrogenation plants at Dahej, strengthening backward integration.

- The Phenolics business achieved record production of Phenol and IPA, with Phenol and Cumene plants operating at over 175% utilisation.

- The company is advancing strategic projects, including entry into Polycarbonate manufacturing and development of MIBK/MIBC plants.

- Sustainability efforts include a 12% reduction in carbon emissions (tCO2e), energy savings of 66,58,755 kWh through renewable energy, and recycling 8,19,575 KL of water.

- The company has over 1,500 customers across 50+ countries and a total workforce of 7,700+ employees.

- Deepak Chem Tech Limited (DCTL) is building India's first integrated Cumene-to-Polycarbonate Resin facility at Dahej, Gujarat, with technology from UOP Honeywell and Trinseo.

- Deepak Phenolics Limited (DPL) operates world-scale facilities with licensed capacities of approximately 300 KTPA of phenol, 180 KTPA of acetone, and 81 KTPA of isopropyl alcohol (IPA).

- Consolidated financial highlights for the year include Revenue of ₹ 7,947 Crores, EBITDA of ₹ 1,041 Crores, Profit After Tax of ₹ 551 Crores, and EPS of ₹ 40.36.

- The Group's Net Worth stood at ₹ 5,837 Crores, with a Market Capitalisation of ₹ 17,567 Crores. A dividend of ₹ 7.50 per share was declared.

- Key projects commissioned or advanced include a Nitric Acid Plant at Nandesari, Hydrogenation-II and integrated Nitration & Hydrogenation-I facilities, and an MIBK/MIBC manufacturing facility.

- A new state-of-the-art Deepak Research & Development Centre (DRDC) was inaugurated at Savli, Vadodara, employing 103 R&D professionals with an investment of ₹ 134 Crores in R&D.

- The Group has 2,522 employees on payroll and 5,216 contractual employees, with total training hours of 1,09,216 and an Employee Engagement score of 65.

- CSR expenditure was ₹ 22.40+ Crores, impacting 7,50,000+ lives. Investment in environment conservation activities was ₹ 16.61 Crores.

- The Group's strategic growth initiatives focus on expanding into downstream derivatives, speciality chemicals, and advanced materials like polycarbonate, moving from bulk chemicals to an integrated chemical solutions platform.

- Key risks identified and managed include global geopolitics, market competition, supply chain disruptions, regulatory compliance, technology obsolescence, and forex volatility.

- Deepak Chem Tech Limited (DCTL) commenced manufacturing operations at its Nitric Acid plant at Nandesari, establishing complete vertical integration across the ammonia-nitration-amines chain.

- Cumene capacity expanded to 172%; Toluidine capacity also expanded, supporting elevated utilisation across key products.

- DCTL commissioned a new Nitration and 2nd Hydrogenation plant at Dahej, strengthening the Group's manufacturing footprint.

- MIBK and MIBC plant is about to be commissioned during Q2 of FY 2026-27, adding acetone-derivative capacity.

- Significant progress on India's first integrated Polycarbonate project (1,65,000 MT/yr): plant dismantling at Stade, Germany completed with equipment shipment to India underway.

- Debottlenecking initiatives raised Phenol capacity to over 165%.

- Achieved highest-ever production and sales volumes in the Phenolics segment in FY 2025-26.

- Other expenses reduced by 10% year-on-year and power and fuel costs reduced by 4% year-on-year in FY 2025-26.

- U.S. Department of Commerce removed Anti-Dumping Duty (45.16%) on Deepak's Sodium Nitrite exports to the United States (January 2026).

- Advanced digitisation of manufacturing operations through SAP S/4HANA migration, AI/ML-driven smart manufacturing systems; Smart Power Optimiser delivering approximately 9% power savings across key plants.

- Target of 60-70% renewable energy mix to be achieved progressively from FY 2026-27 in Deepak Nitrite.

- Inaugurated the Deepak Research and Development Centre at Savli, Vadodara - a world-class ₹ 100 Crores investment spread across a 5-acre campus, housing over 100 researchers.

- Expanded product count to 36+ during FY 2025-26 (from 34+ in FY 2024-25).

- Achieved a 16.5% reduction in emission intensity; over 8 Lakh KL of water recycled (24% reuse rate); 86% waste recycled; 40 hectares of mangrove restoration and over 90,000 Mangroves saplings planted.

- CSR investments reached ₹ 22.40+ Crores in FY 2025-26, impacting over 7,50,000 beneficiaries across 22 districts, 4 states, and 2,000+ villages.

- The Company reported consolidated revenue of ₹ 7,947 Crores, compared with ₹ 8,366 Crores in the previous year.

- The Company delivered EBITDA of ₹ 1,041 Crores, representing an EBITDA margin of approximately 13.1%.

- Profit Before Tax stood at ₹ 770 Crores, while Profit After Tax for the year was ₹ 551 Crores.

- The Board of Directors has recommended a Final Dividend of ₹ 7.50 (375%) per equity share for FY 2025-26.

- Deepak has outlined a cumulative investment pipeline of approximately ₹ 11,500 Crores.

- As at March 31, 2026, the Company's consolidated net worth stood at approximately ₹ 5,837 Crores.

- Total Workforce including contract workers: 7,738.

- Total females in the workforce: 264.

- Hours of training provided: 1,09,000+.

- LTIFR: 0.12.

- Employee engagement score of 65 in AIKYAM Employee Engagement Survey 2025.

- CSR spend of ₹22.41 Crores in FY 2025-26.

- CSR initiatives covered 2,022 villages across 22 unique Districts in 4 states, benefiting 7,53,119 people.

- Deepak Multispeciality Hospital, Dahej, a 50-bed facility, served beneficiaries within 3 months of operations starting January 1, 2026.

- Nidaan Van mobile medical units reached 63,907 beneficiaries for TB and health screenings.

- Mobile Mammography Unit screened 6,000+ women for breast cancer across 119 villages in 4 talukas.

- Women-Centric Mobile Health Unit (Swasthya Sakhi) reached 10,845 beneficiaries.

- DMF Hospital, Nandesari, a 28-bed facility, served 25,182 beneficiaries in FY 2025-26.

- Samaj Suraksha Sankul supported 499 individuals.

- Project Jal Sanchay Yojana benefited 1,189 people.

- Project Sangaath facilitated 2,03,117 approved applications (~90% of submitted) for 43,522 households across 223 villages.

- Under Project Sangaath, 572 housing applications were facilitated, with ₹1.20 Lakhs assistance per family and ₹574.80 Lakhs total sanctioned.

- Mangrove Restoration Project planted 90,000+ saplings and supported livelihoods of 2,279 community members.

- Supplier base includes 3,400+ suppliers.

- Customer base includes 1,500+ customers across 36+ countries, with 50+ product applications and 56+ high-valued products.

- ~80% repeat customer ratio.

- GHG emissions were 12,95,355 MTCO2e across Scope 1, 2 & 3 (12% down from last year).

- Energy procured from renewable sources was 2,39,71,519 MJ (10.7 times higher than last year).

- Water recycled was 8,19,575 KL (24% of total withdrawal, 10% more than last year).

- Total waste recycled was 60,850 MT (86% of total waste).

- Rainwater harvesting saved 5,046 KL of water.

- Treated wastewater discharge reduced by 129 KL compared to FY 2024-25.

- Nil instances of breach of code, human rights violations, or cyber security breaches in FY 2025-26.

- Board comprises 12 Directors with an average age of 36 years and significant cumulative experience.

- S&P Global CSA score improved to 67/100 in FY 2024-25 from 56/100 in FY 2023-24.

- CDP scores: Climate (B), Water (B) in FY 2024-25.

- Awards: S&P Global Sustainability Yearbook 2026 member; Platinum at 19th ICC Environment Excellence Awards.

- Shri Maulik Mehta and Shri Meghav Mehta appointed as Deputy Managing Directors effective May 9, 2026.

- Shri Maulik Mehta (43) holds degrees from University of Liverpool, Columbia University, and Harvard Business School. He is an ESG champion and led the company through the COVID-19 pandemic.

- Shri Meghav Mehta (39) is a Mechanical Engineer from Rochester Institute of Technology. He played a crucial role in the growth of DPL and execution of projects for downstream products of Phenol and Acetone.

- Shri Sanjay Upadhyay (64) is Director (Finance) & Group CFO, a qualified Cost Accountant and Company Secretary with over 40 years of experience.

- Shri Girish Satarkar (62) is Executive Director with over 37 years of experience in the Chemical Industry.

- Shri Ajay C. Mehta is a Non-Executive Director and was the Managing Director of the company from December 1989 till December 2017.

- The global economy is undergoing structural transformation with supply-chain realignment and regionalisation. IMF projects global growth at 3.1% in 2026 and 3.2% in 2027.

- India's GDP is projected to grow around 6.5% in 2026 and 6.5% in 2027, making it the fastest-growing major economy.

- Union Budget 2026-27 announced a new scheme to establish three dedicated Chemical Parks with an allocation of ₹ 600 Crores.

- The Budget also allocated ₹ 20,000 Crores to support Carbon Capture, Utilisation and Storage (CCUS).

- The global chemical industry faces persistent overcapacity, particularly in China, leading to margin pressure. Growth is shifting to high-value segments like Speciality chemicals and sustainable materials.

- The Indian chemical industry is expected to reach approximately US$ 400 billion by 2030 and has the potential to scale up to US$ 1 trillion by 2040.

- A strategic emphasis is placed on minimising dependency on imported chemicals to reduce supply chain vulnerabilities and a widening trade gap.

- Key growth drivers for India include expanding domestic consumption, global supply chain realignment (China+1), and a shift towards Speciality and High-Value Chemicals.

- Company reported consolidated revenue of ₹ 7,887 Crores for FY 2025-26, with domestic revenues of ₹ 6,703 Crores and exports of ₹ 1,184 Crores.

- Consolidated EBITDA stood at ₹ 1,041 Crores, with Profit After Tax of ₹ 551 Crores.

- Deepak Phenolics Limited (DPL) reported revenue of ₹ 5,401 Crores and EBIT of ₹ 695 Crores, with an EBIT margin of 13%.

- Advanced Intermediates (AI) segment reported revenue of ₹ 2,553 Crores and EBIT of ₹ 107 Crores.

- The Board recommended a final dividend of ₹ 7.50 per equity share (375% of face value) for FY 2025-26.

- The Company is undertaking a major capital expenditure program exceeding ₹ 11,500 Crores, including a flagship Polycarbonate project.

- A new integrated Polycarbonate manufacturing facility with a capacity of 1,65,000 MTPA is planned at Dahej, with commissioning expected by 2029.

- Commissioned a new Research & Development Centre at Savli, Vadodara, with an investment of approximately ₹ 100 Crores.

- Secured a 15-year feedstock supply agreement with Petronet LNG for 250 KTPA of propylene and 11 KTPA of hydrogen.

- The Company improved its EcoVadis score to 71/100 (Bronze Medal) and its Dow Jones Sustainability Index (DJSI) score to 67/100 (94th percentile).

- Deepak Chem Tech Limited (DCTL) employed over ~2,800 personnel as of March 31, 2026.

- Export revenues accounted for 34% of standalone revenues, down from 45% in the previous year, with a consolidated Domestic-to-Export revenue mix of 85:15.

- The company maintained a debt-free position on a net basis with a Debt Equity Ratio of 0.

- Profitability metrics declined year-over-year: Return on Net Worth decreased to 5.87% (from 8.84%), Operating Profit Margin (EBIT) decreased to 8.68% (from 12.76%), and Net Profit Margin (PBT) decreased to 8.54% (from 10.94%). The decrease is attributed to subdued agrochemical demand, global oversupply, and pricing pressure.

- A final dividend of ₹ 7.50 per equity share (375% of face value) is proposed, amounting to ₹ 102,29,47,807.50.

- The 55th Annual General Meeting (AGM) is scheduled for August 5, 2026.

- Key management appointments and re-appointments are proposed: Shri Anant Pande (DIN: 08186854) to be appointed as Executive Director & CMO; Shri Maulik Mehta (DIN: 05227290) to be re-appointed and elevated as Deputy Managing Director; Shri Meghav Mehta (DIN: 05229853) to be elevated and appointed as Deputy Managing Director; Shri Sanjay Upadhyay (DIN: 01776546) to be re-appointed as Director (Finance) & Group CFO; Shri Girish Satarkar (DIN: 00340116) to be re-appointed as Executive Director; and Shri Milin Mehta (DIN: 01297508) to be appointed as an Independent Director.

- The company is undergoing a major strategic transformation with a multi-year capital expenditure program estimated at ₹ 8,000 Crores to ₹ 10,000 Crores, including a significant investment of approximately ₹ 11,500 Crores in an integrated Phenol to Polycarbonate (PC) resin project at Dahej.

- Other strategic investments include about ₹ 600 Crores for manufacturing Speciality Chemicals and Performance Products, and the commissioning of MIBK and MIBC projects.

- The company's SWOT analysis highlights strengths like integrated manufacturing and a diversified portfolio, and weaknesses such as dependence on conventional energy and input cost volatility. Opportunities include import substitution and the China+1 strategy, while threats include global oversupply and geopolitical uncertainties.

- Consolidated Total Income for FY 2025-26 was ₹ 7,947 Crores, a decrease of 5.01% from the previous year. Consolidated Profit After Tax was ₹ 551 Crores.

- The company employed 3,858 personnel (including contract workers) on a standalone basis and 7,738 on a consolidated basis as of March 31, 2026.

- Appointment of Shri Adnan Ahmad (DIN: 00046742) as an Independent Director for a term of three consecutive years, effective from August 7, 2026 to August 6, 2029.

- Approval for payment of remuneration to Executive Directors who are Promoters or members of the Promoter Group, exceeding ₹ 5 Crores or 2.5% of net profits (whichever is higher) for an individual, or an aggregate exceeding 5% of net profits for multiple such directors.

- The remuneration approval for Executive Directors is effective from the Financial Year commencing April 1, 2026, and for subsequent years until the expiry of their respective terms.

- Ratification of remuneration of ₹ 8,50,000 (Rupees Eight Lakhs Fifty Thousand only) plus applicable tax and expenses to the Cost Auditor, B. M. Sharma & Co., for the Financial Year 2026-27.

- The Board has recommended a final dividend of ₹ 7.50 per equity share for the Financial Year 2025-26, payable within 30 days of the AGM approval.

- The 55th Annual General Meeting (AGM) will be held through Video Conferencing (VC) or Other Audio Visual Means (OAVM) on August 5, 2026, with remote e-Voting available from August 2, 2026 (9:00 AM IST) to August 4, 2026 (5:00 PM IST).

- The record date for determining members eligible for dividend and voting is Monday, July 27, 2026.

- Shri Dinesh Joshi, Practising Company Secretary, has been appointed as the Scrutiniser for the e-Voting process.

- Shri Ajay C. Mehta (DIN: 00028405), a Non-Independent Non-Executive Director, will retire by rotation on August 5, 2026 and is not offering himself for re-appointment.

- Shri Anant Pande (DIN: 08186854) is recommended for appointment as a Director liable to retire by rotation, replacing Shri Ajay C. Mehta.

- Shri Anant Pande is also recommended for appointment as Whole-time Director & Chief Manufacturing Officer for 3 years from August 5, 2026.

- Shri Anant Pande's remuneration for FY 2026-27 includes Fixed Remuneration of ₹ 2.40 Crores per annum and Variable Pay up to ₹ 1 Crore.

- Shri Maulik Mehta (DIN: 05227290) is recommended for re-appointment and elevation as Deputy Managing Director for 5 years from May 9, 2026 till May 8, 2031.

- Shri Maulik Mehta's remuneration for FY 2026-27 includes Fixed Remuneration of ₹ 5.00 Crores per annum and Variable Pay ranging from 0% to 35% of Fixed Remuneration.

- Shri Meghav Mehta (DIN: 05229853) is recommended for elevation and appointment as Deputy Managing Director for 5 years from May 9, 2026 till May 8, 2031.

- Shri Meghav Mehta's remuneration for FY 2026-27 includes proportionate Fixed Remuneration of ₹ 4.00 Crores per annum and Variable Pay ranging from 0% to 35% of Fixed Remuneration.

- Shri Sanjay Upadhyay (DIN: 01776546) is recommended for re-appointment as Director (Finance) & Group CFO for 5 years from August 1, 2026 till July 31, 2031.

- Shri Sanjay Upadhyay's remuneration for FY 2026-27 includes Fixed Remuneration of ₹ 5.60 Crores per annum and Variable Pay ranging from 0% to 35% of Fixed Remuneration.

- Shri Girish Satarkar (DIN: 00340116) is recommended for re-appointment as Executive Director for 3 years from August 4, 2026 till August 3, 2029.

- Shri Girish Satarkar's remuneration for FY 2026-27 includes Fixed Remuneration of ₹ 2.30 Crores per annum and Variable Pay ranging from 0% to 35% of Fixed Remuneration.

- Shri Milin Mehta (DIN: 01297508) is recommended for appointment as an Independent Director for 3 years from August 7, 2026 till August 6, 2029, replacing Shri Dileep Choksi.

- Shri Adnan Ahmad (DIN: 00046742) is recommended for appointment as an Independent Director for 3 years from August 7, 2026 till August 6, 2029.

- A Special Resolution (Item No. 13) seeks shareholder approval for flexibility in paying remuneration to Executive Directors who are Promoters/Promoter Group members, in excess of limits under SEBI Listing Regulations.

- B. M. Sharma & Co., Cost Accountants (Firm Reg. No. 00219) is recommended for re-appointment as Cost Auditor for FY ending March 31, 2027, with remuneration fixed at ₹ 8,50,000 plus taxes and expenses.

- Deepak Nitrite Limited (DNL) proposes the appointment of Shri Anant Pande as an Independent Director effective August 5, 2026. He was previously CEO of Dhampur Sugar Mills and Whole-time Director & Chief of Operations at Jubilant Life Sciences.

- Shri Maulik Mehta (DIN: 05227290), Executive Director & CEO, is being elevated to Deputy Managing Director. He received total remuneration of ₹ 5.38 Crores (Fixed: ₹ 4.54 Crores, Variable: ₹ 0.84 Crores) in FY 2025-26 and holds 1,31,300 equity shares.

- Shri Meghav Mehta (DIN: 05229853), Non-Executive Director, is being elevated and appointed as Deputy Managing Director. He received total remuneration of ₹ 0.17 Crores (Sitting Fees: ₹ 0.02 Crores, Commission: ₹ 0.15 Crores) in FY 2025-26 and holds 47,290 equity shares.

- Shri Sanjay Upadhyay, Director (Finance) & Group CFO, received total remuneration of ₹ 6.53 Crores (Fixed: ₹ 5.49 Crores, Variable: ₹ 1.04 Crores) in FY 2025-26 and holds 1,738 equity shares.

- Shri Girish Satarkar, Independent Director, received total remuneration of ₹ 2.71 Crores (Fixed: ₹ 2.44 Crores, Variable: ₹ 0.27 Crores) in FY 2025-26 and holds 12 equity shares.

- The company proposes the appointment of Shri Milin Mehta and Shri Adnan Ahmad as Independent Directors effective August 7, 2026.

- Standalone financial results for FY 2025-26: Total Revenue ₹ 2,760.32 Crores, EBITDA ₹ 344.33 Crores, Profit Before Tax ₹ 225.10 Crores, Net Profit ₹ 188.88 Crores.

- Consolidated financial results for FY 2025-26: Total Revenue ₹ 7,946.94 Crores, EBITDA ₹ 1,040.59 Crores, Profit Before Tax ₹ 757.09 Crores, Net Profit ₹ 550.66 Crores.

- Subsidiary Deepak Phenolics Limited (DPL) reported Revenue of ₹ 5,411 Crores and Profit After Tax of ₹ 540 Crores for FY 2025-26, including SGST remission of ₹ 102 Crores from Gujarat Government.

- Subsidiary Deepak Chem Tech Limited (DCTL) commissioned a Nitric Acid plant at Nandesari with capex of ~₹ 515 Crores, and Hydrogenation & Nitration facilities with capex of ~₹ 115 Crores and ~₹ 85 Crores respectively.

- DCTL is setting up MIBK & MIBC plants and two speciality chemical plants at Dahej, expected commissioning in Q2 FY 2026-27.

- DCTL is implementing an integrated Polycarbonate (PC) resin plant at Dahej with an approximate capex of ₹ 11,500 Crores, which will be India's first PC manufacturing plant.

- The 55th Annual General Meeting (AGM) is scheduled for 11:30 AM (IST) on Wednesday, August 5, 2026, to be held through Video Conferencing.

- The Board has recommended a Final Dividend of ₹ 7.50 per equity share for FY 2025-26.

- The Board recommended a Dividend of ₹ 7.50 per Equity Share (face value ₹ 2.00), which is 375%. The total dividend outgo would be ₹ 102.29 Crores, representing a 54.15% payout of Standalone PAT.

- Consolidated Total Income for FY 2025-26 was ₹ 7,947 Crores, down 5% from ₹ 8,366 Crores in the previous year.

- Consolidated EBITDA was ₹ 1,041 Crores, down 11% from ₹ 1,176 Crores in FY 2024-25, primarily due to compressed spreads from higher input costs.

- Consolidated Profit After Tax (PAT) was ₹ 551 Crores. Profit Before Tax (PBT) stood at ₹ 770 Crores (excluding an Exceptional Item of ₹ 13 Crores).

- Domestic Revenues were ₹ 6,703 Crores, while Export Revenues were ₹ 1,184 Crores.

- The Company's Consolidated Net Worth as of March 31, 2026, was ₹ 5,837 Crores.

- Subsidiary Deepak Chem Tech Limited (DCTL) reported a loss of ₹ 63.75 Crores in FY 2025-26, compared to a loss of ₹ 45.02 Crores in the prior year.

- Subsidiary Deepak Advanced Materials Limited (DAML) reported a Total Income of ₹ 29.50 Crores and a Loss After Tax of ₹ 15.18 Crores.

- The Company is expanding its Polycarbonate (PC) resin project. New Phenol and Acetone capacities will be integrated for PC production, aiming to make Deepak one of the most integrated PC producers globally.

- DCTL entered a strategic long-term agreement for a dedicated onsite HyCO plant at Dahej under a Build-Own-Operate (BOO) model during FY 2025-26.

- The Company's credit ratings were reaffirmed: ICRA AA for long-term and ICRA A1+ for short-term. Subsidiary Deepak Phenolics Limited also holds ICRA AA/A1+ ratings.

- The Record Date for the FY 2025-26 dividend is Monday, July 27, 2026.

- The issued, subscribed, and paid-up Equity Share Capital as of March 31, 2026, is ₹ 27.28 Crores, comprising 13,63,93,041 Equity Shares of ₹ 2.00 each.

- Several changes were made to the Board and Key Managerial Personnel, including the re-appointment and elevation of Shri Maulik Mehta and Shri Meghav Mehta as Deputy Managing Directors effective May 9, 2026.

- The Statutory Auditors (Deloitte Haskins & Sells LLP), Secretarial Auditors (KANJ & Co. LLP), and Cost Auditors (B. M. Sharma & Co.) were re-appointed. The Cost Auditor's remuneration for FY 2026-27 is ₹ 8,50,000 plus taxes.

- CSR spending for FY 2025-26 was ₹ 9.64 Crores, exceeding the statutory requirement of ₹ 8.68 Crores by ₹ 0.96 Crores.

- The excess CSR amount of ₹ 0.96 Crores is eligible for set-off against CSR obligations for the next three financial years.

- CSR initiatives are implemented through Deepak Foundation and other organizations, focusing on healthcare, education, and livelihood enhancement.

- Deepak Medical Foundation (DMF) Hospital in Nandesari is a 28-bedded multi-speciality facility with a 10-bedded ICU.

- The company inaugurated a new state-of-the-art R&D centre (DRDC) at Savli, Vadodara in October 2025, spread across 20,000 sq. metres.

- The R&D centre has a dedicated team of 103 professionals and the company has cumulatively filed around 86 patent applications, with 26 patents granted.

- Deepak Chem Tech Limited (DCTL), a material subsidiary, approved setting up a manufacturing complex with an aggregate investment of around ₹ 3,500 Crores.

- DCTL commissioned several plants: a Hydrogenation Plant (approx. ₹ 115 Crores), a Nitric Acid Plant (approx. ₹ 515 Crores), and a Nitration and 2nd Hydrogenation Plant (approx. ₹ 85 Crores).

- The company declared a dividend of ₹ 7.50 per equity share (face value ₹ 2.00) for FY 2024-25.

- No complaints of sexual harassment were received or pending during the financial year.

- The company received awards for 'Best Responsible Care Committed Company' (2024) and 'Safety Achievement Award' (FY 2024-25).

- As part of green initiatives, over 55,000 native trees were planted across 50 hectares in Maharashtra.

- Industrial relations remained harmonious with zero mandays lost during FY 2025-26.

- Deepak Nitrite Limited (DNL) published its Business Responsibility & Sustainability Report (BRSR) for FY 2025-26, prepared on a standalone basis.

- The company reported a 12.2% reduction in absolute greenhouse gas (GHG) emissions during FY 2025-26.

- DNL restored 40 hectares of degraded coastal land through mangrove plantation during the year.

- The company's paid-up capital is ₹ 27,27,86,082.

- Turnover for FY 2025-26 was ₹ 2,760.32 Crores and net worth was ₹ 3,215.33 Crores.

- Exports contributed 37% of the total turnover.

- Total workforce comprises 1,321 employees and 2,537 workers. The workforce includes 10 differently-abled individuals (2 employees, 8 workers).

- The Board of Directors has 12 members, including 1 woman (8.33% representation).

- DNL was included in the S&P Global Sustainability Yearbook 2026.

- The company has 7 subsidiary companies, including Deepak Phenolics Limited and Deepak Chem Tech Limited.

- Customer complaints received during the year were 78, all of which were resolved. Shareholder complaints were 7, with 1 resolved post-year-end.

- The report was assured by Bureau Veritas (India) Private Limited, providing Reasonable Assurance for BRSR Core and Limited Assurance for the full BRSR Report.

- Accounts payable days were 76 days in FY 2025-26, slightly down from 77 days in FY 2024-25.

- Purchases from trading houses were 53.00% of total purchases (FY 2025-26), down from 59.45% in the previous year, with purchases from 1,228 trading houses.

- Purchases from related parties (RPTs) increased to 13.88% of total purchases in FY 2025-26 from 9.23% in FY 2024-25.

- Loans and advances to related parties constituted 96.18% of total loans and advances in FY 2025-26.

- Investments in related parties were 89.51% of total investments in FY 2025-26.

- The company conducted 3 awareness programs for value chain partners on sustainability topics, covering 41% and 2% of partners by business value.

- Capex investments in technologies to improve environmental/social impacts were 9.01% of total capex in FY 2025-26, up from 3.94% in the prior year. R&D investment for this purpose was 0.00%.

- 44% of inputs were sourced sustainably in FY 2025-26.

- The company reclaimed and recycled 1,618 metric tonnes of plastics/packaging waste in FY 2025-26.

- All permanent employees (100%) were covered by health and accident insurance. 100% of permanent workers were also covered.

- Spending on employee/worker well-being measures was 0.25% of total revenue in both FY 2025-26 and FY 2024-25.

- 100% of employees and workers were covered by PF, Gratuity, and ESI schemes, with dues deposited.

- Lost Time Injury Frequency Rate (LTIFR) for employees was 0.12 per million person-hours in FY 2025-26, improving from 0.29.

- There were 6 recordable work-related injuries for employees and 7 for workers in FY 2025-26, with zero fatalities.

- 28.08% of employees and 20.65% of workers received human rights training in FY 2025-26.

- 100% of permanent employees and 100% of permanent workers were paid more than the minimum wage. 100% of other-than-permanent workers were paid equal to the minimum wage.

- Gross wages paid to females were 3.21% of total wages in FY 2025-26.

- There were zero complaints filed on sexual harassment, discrimination, child labour, forced labour, or wages in FY 2025-26.

- Total energy consumption was 20,92,268.72 GJ in FY 2025-26, with 23,395.95 GJ from renewable sources.

- Energy intensity was 0.00007927 GJ per rupee of turnover and 7.6069 GJ per MT of production in FY 2025-26.

- Total water withdrawal was 12,09,161 kilolitres in FY 2025-26, all from third-party sources.

- Water intensity was 0.00002796 kilolitres per rupee of turnover and 2.4683 kilolitres per MT of production in FY 2025-26.

- Environmental compliance and performance data for FY 2025-26 and FY 2024-25 has been independently assured by Bureau Veritas (India) Private Limited.

- Water discharge: Total water discharged was 4,71,255 kilolitres (FY 2025-26) and 5,02,284 kilolitres (FY 2024-25), all sent to third-parties with treatment. No discharge to surface water, groundwater, or seawater.

- Zero Liquid Discharge (ZLD) system is implemented at the Hyderabad Unit-II, treating high TDS effluents and sewage for reuse.

- Air emissions: Key emissions for FY 2025-26 were NOx: 611 TPA, SOx: 137 TPA, and Particulate Matter: 98 TPA.

- Greenhouse Gas Emissions: Total Scope 1 emissions were 1,28,794.15 metric tonnes of CO2 equivalent and Scope 2 emissions were 87,734.01 metric tonnes of CO2 equivalent for FY 2025-26. Total Scope 3 emissions were 2,16,491.82 metric tonnes of CO2 equivalent.

- Waste Management: Total waste generated was 67,822.71 MT (FY 2025-26), of which 58,155.64 MT (86%) was sent for reuse/recycle/recovery. Plastic waste was 1,729.61 MT and other hazardous waste was 58,936.57 MT.

- The company is fully compliant with applicable environmental laws (Water Act, Air Act, Environment Protection Act) and holds valid SPCB consents.

- An Environmental Impact Assessment (EIA) was conducted for an expansion project at the Hyderabad Unit-II (SIA/TG/IND3/556853/2025, dated 02/05/2026) by an external agency.

- In water-stress areas (Nandesari, Dahej, Jeedimetla), total water withdrawal was 10,58,149 kilolitres and consumption was 6,39,036 kilolitres for FY 2025-26, sourced entirely from third parties.

- Key initiatives to improve resource efficiency include installing a Mechanical Vapour Recovery (MVR) unit, reusing process vapour, and recovering copper sulphate from waste.

- The company has a business continuity and disaster management plan (On-Site and Off-Site Emergency Action Plan).

- CSR spending for FY 2025-26 was ₹9.64 Crores against a requirement of ₹8.68 Crores, with an excess of ₹0.96 Crores available for set-off. Key projects include 'Help Desk', medical services, and education initiatives.

- Consumer complaints: 78 complaints were received in FY 2025-26 (all resolved), related to delivery, packing, and handling. There were no complaints on data privacy, advertising, or cybersecurity.

- The company is a member of 5 trade/industry associations including FICCI, Indian Chemical Council, and CII.

- 13.95% of input materials (by value) were sourced directly from MSMEs/small producers in FY 2025-26.

- An independent reasonable assurance report was provided by Bureau Veritas on 9 BRSR-Core indicators, confirming the data is free from material misstatement.

- Unspent CSR amount for FY 2024-25 and 2023-24 is Nil. For FY 2022-23, ₹0.70 Crores was transferred to the unspent CSR account and the same amount (₹0.70 Crores) was spent in the financial year, leaving a balance of Nil.

- Capital assets were created/acquired through CSR spend. The total CSR spent on capital assets in the financial year was ₹4,06,958/- (plus an additional ₹5,515/- noted). Assets include furniture, medical equipment, computers, and printers for various health and education projects across locations like Vadodara, Roha, Raigad, and Hyderabad.

- The company has not failed to spend the mandated 2% of average net profit on CSR; the reason specified is 'Not Applicable'.

- A revised Nomination and Remuneration Policy was adopted by the Board on May 15, 2026. It outlines the framework for appointing and determining remuneration for Directors, Key Managerial Personnel (KMP), and Senior Management.

- Disclosure under Section 197(12) shows the ratio of each director's remuneration to the median employee remuneration for FY 2025-26. For example, the Chairman & Managing Director's remuneration is 107.88 times the median, while Independent Directors' ratios are 1.88.

- Percentage increase in remuneration for FY 2025-26 for key executives: Chairman & MD (0.23%), Director (Finance) & Group CFO (9.38%), Executive Director & CEO (8.69%), and Executive Director (11.52%). Independent Directors' increase was 0.00%.

- The median employee remuneration increased by 10% in FY 2025-26. The average percentile increase for non-managerial personnel was 11.40%, while for managerial personnel it was 7.46%.

- Dr. (Hon.) Deepak C. Mehta, Chairman & MD, received a profit-related commission of ₹18 Crores from the wholly-owned subsidiary Deepak Phenolics Limited for FY 2025-26.

- Steps for energy conservation included installing VFDs, optimizing cooling towers and distillation columns, replacing lighting with LEDs, and heat recovery projects, leading to reduced power and steam consumption.

- The company entered into long-term group captive agreements for renewable power, aiming to replace ~70% of conventional power. In FY 2025-26, ~20.6 million units of renewable power were procured, replacing ~20% of consumption at Nandesari, Dahej, and Roha facilities.

- Energy conservation capex approved in FY 2025-26 totaled ₹18.13 Crores.

- A new Research & Development Centre was commissioned with an investment exceeding ₹100 Crores. Efforts were made in technology absorption, including developing indigenous technologies for import-substituting products.

- Multiple new products successfully developed and being scaled up, with benefits expected from FY27 onwards.

- R&D expenditure for 2025-26 was ₹133.18 Crores (Capital: ₹102.85 Crores, Recurring: ₹30.33 Crores), up from ₹22.33 Crores in 2024-25.

- R&D expenditure as a percentage of total turnover increased to 5.05% in 2025-26 from 0.88% in 2024-25.

- Total Foreign Exchange Earned in 2025-26 was ₹968.69 Crores (2024-25: ₹1,141.32 Crores).

- Total Foreign Exchange Outgo in 2025-26 was ₹458.78 Crores (2024-25: ₹439.27 Crores).

- In-house technology developed in last 3 years: 5 Nos. Applied for patent: 3 Nos.

- Board composition as of March 31, 2026: 12 Directors (4 Executive, 8 Non-Executive including 6 Independent Directors).

- Key leadership changes: Shri Maulik Mehta and Shri Meghav Mehta elevated to Deputy Managing Directors effective May 9, 2026.

- New Independent Directors appointed: Dr. Arvind Nath Agrawal, Shri Mahesh Chhabria, and Ms. Bhumika Batra effective June 28, 2025.

- Five Board meetings held during FY 2025-26, with 100% attendance by most directors including Dr. Deepak C. Mehta (Chairman & MD).

- Audit Committee held 4 meetings in FY 2025-26 with 100% attendance by Shri Dileep Choksi, Shri Vipul Shah, and Shri Mahesh Chhabria.

- Nomination and Remuneration Committee held 3 meetings; Dr. (Hon.) Deepak C. Mehta attended 2 out of 3 (66.67% attendance).

- Stakeholders' Relationship & Investors Grievance Committee held 4 meetings; all members (Shri Ajay C. Mehta, Shri Sanjay Upadhyay, Shri Punit Lalbhai) attended 3 out of 4 (75% attendance).

- Investor complaints: 07 received, 06 resolved, 01 pending at year-end (subsequently disposed by SEBI on April 17, 2026).

- Corporate Social Responsibility Committee held 2 meetings with 100% attendance by all members.

- Risk Management Committee held 2 meetings; Dr. (Hon.) Deepak C. Mehta attended 1 out of 2 (50% attendance).

- Sustainability Committee held 2 meetings; Shri Maulik Mehta attended 1 out of 2 (50% attendance).

- Total remuneration for Chairman & Managing Director and Executive Directors in FY 2025-26 was ₹ 23.24 Crores.

- Total commission paid to Independent and Non-Executive Directors was ₹ 1,55,00,000, with total sitting fees of ₹ 25,20,000.

- A Postal Ballot was conducted from April 26, 2025, to May 25, 2025, for appointment/re-appointment of Independent Directors; all 5 Special Resolutions were passed.

- Key Managerial Personnel include Dr. (Hon.) Deepak C. Mehta (CMD), Shri Maulik Mehta (Deputy MD from May 9, 2026), Shri Sanjay Upadhyay (Director Finance & Group CFO), Shri Girish Satarkar (Executive Director), Shri Somsekhar Nanda (CFO), and Shri Arvind Bajpai (Company Secretary).

- The 55th Annual General Meeting (AGM) will be held on Wednesday, August 5, 2026, at 11:30 A.M. (IST) through Video Conferencing / Other Audio Visual Means.

- The record date for dividend is July 27, 2026. The dividend will be paid on or before September 4, 2026.

- The company's equity shares are listed on BSE (Stock Code: 506401) and NSE (Stock Code: DEEPAKNTR) with ISIN INE288B01029.

- Total paid-up equity share capital as on March 31, 2026, is ₹ 27,27,86,082 divided into 13,63,93,041 Equity Shares of ₹ 2.00 each.

- Shareholding distribution as on March 31, 2026: 98.54% of holders (4,00,880) own 8.22% of equity, while 0.09% of holders (381) own 84.04% of equity.

- Promoters & Promoters Group hold 49.33% (6,72,80,498 shares) of the equity capital.

- 99.78% of the company's total equity share capital (13,60,96,326 shares) was held in dematerialized form as on March 31, 2026.

- Unclaimed dividend of ₹ 11,38,802/- pertaining to Financial Year 2017-18 and 35,435 shares were transferred to the IEPF account during FY 2025-26.

- Total fees paid/payable to Statutory Auditors (Deloitte Haskins & Sells LLP) for all services on a consolidated basis was ₹ 1.64 Crores.

- The company has two material subsidiaries: Deepak Phenolics Limited and Deepak Chem Tech Limited.

- The company's long-term credit rating is [ICRA]AA (Stable) and short-term rating is [ICRA]A1+.

- No penalties or strictures were imposed on the company by any Stock Exchange, SEBI, or statutory authority relating to capital markets in the last three financial years.

- The company participated in the 'Saksham Niveshak' campaign to create awareness about unclaimed dividends and guide shareholders to update KYC and nomination details.

- Auditor Deloitte Haskins & Sells LLP issued an unmodified (clean) audit opinion on the standalone financial statements for the year ended 31st March 2026.

- The auditor also expressed an unmodified opinion on the adequacy and operating effectiveness of the company's internal financial controls.

- Revenue from operations for FY 2026 was ₹ 2,639.46 Crores, compared to ₹ 2,526.47 Crores in FY 2025.

- Profit before tax (after exceptional items) for FY 2026 was ₹ 225.10 Crores, down from ₹ 337.54 Crores in FY 2025.

- Profit for the year (net profit) was ₹ 188.88 Crores, compared to ₹ 276.43 Crores in the previous year.

- Basic and diluted Earnings Per Share (EPS) for FY 2026 was ₹ 13.85, down from ₹ 20.27 in FY 2025.

- Total assets as of 31st March 2026 stood at ₹ 3,806.74 Crores, up from ₹ 3,617.47 Crores the previous year.

- Total equity as of 31st March 2026 was ₹ 3,215.33 Crores.

- The company paid a dividend of ₹ 102.29 Crores during the year and has proposed a final dividend for the year, subject to shareholder approval.

- The company provided loans and guarantees to subsidiaries during the year: Loans of ₹ 36.50 Crores and guarantees of ₹ 47.33 Crores (outstanding).

- The company has not defaulted in repayment of loans or interest to any lender during the year.

- No fraud by the company or material fraud on the company was noticed or reported during the year.

- The company has not incurred cash losses during the current or immediately preceding financial year.

- The company has transferred unspent CSR amounts for ongoing projects to a special account as required by law.

- The financial statements were approved by the Board of Directors on 15th May 2026, signed by Chairman & Managing Director Deepak C. Mehta and other key officials.

- The company has adopted various amendments to Indian Accounting Standards (Ind AS) including guidance on classification of liabilities with covenants, disclosure requirements for supplier finance arrangements, and temporary mandatory exemption from deferred tax accounting for Pillar Two Model Rules top-up taxes.

- The company states there is no material impact on its Financial Statements from the amendments to Ind AS 21 regarding exchangeability between currencies and estimating spot rates.

- Standalone Financial Statements are prepared on a historical cost basis, except for certain financial assets/liabilities, derivative instruments, and defined benefit plan assets which are measured at fair value.

- The functional and presentation currency is Indian Rupees (INR).

- Key accounting estimates include useful lives and residual value of property, plant and equipment, allowance for expected credit losses, fair value of investments, and provisions for income taxes.

- Property, Plant and Equipment as at March 31, 2026 has a Gross Carrying Amount of ₹1,690.73 crores and a Net Carrying Amount of ₹1,038.97 crores.

- Depreciation is provided based on rates prescribed by Schedule II to the Companies Act, 2013, with certain plant & equipment components depreciated over technically assessed useful lives ranging from 3 to 40 years.

- Capital work-in-progress as at March 31, 2026 is ₹65.78 crores, mainly comprising addition/expansion projects.

- Revenue from sale of goods is recognized when control transfers, net of GST, trade discounts, and rebates.

- The company recognizes right-of-use assets and lease liabilities for leases longer than twelve months, with short-term and low-value lease payments expensed on a straight-line basis.

- CWIP (Capital Work in Progress) decreased significantly to ₹65.78 Crores as of March 31, 2026, from ₹170.42 Crores a year earlier.

- Total Property, Plant and Equipment (PPE) increased, with Gross Carrying Amount for owned assets rising to ₹150.39 Crores (Mar 2026) from ₹50.68 Crores (Mar 2025).

- Non-Current Investments increased to ₹1,410.17 Crores (Mar 2026) from ₹1,283.86 Crores (Mar 2025), including a ₹120.50 Crores increase in preference shares of subsidiary Deepak Chem Tech Limited.

- Current Investments (Mutual Funds) rose to ₹155.46 Crores (Mar 2026) from ₹88.59 Crores (Mar 2025).

- Inventory decreased to ₹421.03 Crores (Mar 2026) from ₹452.34 Crores (Mar 2025), with Finished Goods down to ₹169.53 Crores from ₹240.05 Crores.

- Trade Receivables stood at ₹594.48 Crores (Mar 2026), slightly down from ₹612.93 Crores (Mar 2025).

- Revenue from Operations increased to ₹2,639.46 Crores (FY26) from ₹2,526.47 Crores (FY25).

- Profit for the year was ₹188.88 Crores (FY26), down from ₹276.43 Crores (FY25).

- Retained Earnings increased to ₹2,653.00 Crores (Mar 2026) from ₹2,564.48 Crores (Mar 2025).

- The company paid a dividend of ₹102.29 Crores on equity shares for both FY26 and FY25.

- Key promoter Dr. (Hon.) Deepak Chimanlal Mehta held 16.56% equity (2,25,92,689 shares) as of March 31, 2026.

- Contingent liabilities and commitments: Total contingent liabilities as of March 31, 2026 are ₹ 47.86 crores (₹ 43.32 crores in 2025), including a corporate guarantee of ₹ 47.33 crores (₹ 42.79 crores in 2025) for a $49 Mn term loan to subsidiary Deepak Oman Industries (SFZ) LLC.

- Tax expense: Total income tax expense for the year ended March 31, 2026 is ₹ 36.22 crores, compared to ₹ 61.11 crores in the previous year. Current tax for the year is ₹ 21.92 crores.

- Profit before taxes: Profit before taxes for the year ended March 31, 2026 is ₹ 225.10 crores, down from ₹ 337.54 crores in the previous year.

- Deferred tax: Net deferred tax liabilities as of March 31, 2026 are ₹ 66.34 crores, an increase from ₹ 50.30 crores in 2025.

- Employee benefits - Gratuity: The present value of the defined benefit obligation for gratuity as of March 31, 2026 is ₹ 68.87 crores (₹ 60.90 crores in 2025). The fair value of plan assets is ₹ 56.90 crores, resulting in a net liability of ₹ 11.97 crores recognized in the balance sheet.

- Employee benefits - Leave: The unfunded leave benefit obligation as of March 31, 2026 is ₹ 42.99 crores (₹ 42.31 crores in 2025).

- Capital management: Total equity as of March 31, 2026 is ₹ 3,215.33 crores. Total borrowings are ₹ 12.97 crores, resulting in a debt-to-equity ratio of 0.40%.

- Interest coverage ratio: The interest coverage ratio (EBITDA/Finance Cost) for the year ended March 31, 2026 is 468.02x, compared to 406.94x in the previous year.

- Financial instruments - Investments: The carrying value of investments as of March 31, 2026 is ₹ 164.25 crores, with ₹ 155.59 crores classified as Fair Value Through Profit or Loss and ₹ 8.66 crores as Fair Value Through Other Comprehensive Income.

- Financial instruments - Trade receivables: Gross trade receivables as of March 31, 2026 are ₹ 603.46 crores, with an allowance for credit loss of ₹ 8.98 crores, resulting in a net carrying amount of ₹ 594.48 crores.

- Financial instruments - Trade payables: Trade payables as of March 31, 2026 are ₹ 346.06 crores, of which ₹ 32.01 crores are owed to MSMEs.

- Foreign currency risk: The company's net open exposure to USD as of March 31, 2026 is an asset of USD 0.25 crores. A ₹ 1 strengthening against the US Dollar would have an impact of ₹ (1.06) crores on profit before tax.

- Analytical ratios: Return on Equity for the year ended March 31, 2026 is 6%, down from 9% in the previous year. Net Profit Ratio is 7%, down from 11%. The company attributes the decrease in profitability to subdued agrochemical demand, global oversupply, and pricing pressure.

- Total revenue for FY26 was ₹2,639.46 Crores, up from ₹2,526.47 Crores in FY25.

- Revenue from India increased to ₹1,670.77 Crores (FY25: ₹1,385.15 Crores), while revenue from Outside India decreased to ₹968.69 Crores (FY25: ₹1,141.32 Crores).

- Total segment assets stood at ₹3,806.74 Crores as of March 31, 2026, up from ₹3,617.47 Crores.

- Net Profit after Tax for the year was ₹188.88 Crores, down from ₹276.43 Crores in FY25.

- Basic and Diluted Earnings Per Share (EPS) for FY26 was ₹13.85, down from ₹20.27 in FY25.

- Total Research and Development expenditure increased significantly to ₹133.18 Crores (FY25: ₹22.33 Crores), with Capital Expenditure of ₹102.85 Crores.

- The company spent ₹9.64 Crores on Corporate Social Responsibility (CSR) activities, exceeding the requirement of ₹8.68 Crores.

- A provision of ₹10.51 Crores was made as an 'Exceptional item' due to the impact of the new Labour Codes.

- The Board recommended a dividend of ₹7.5 per equity share for FY26, amounting to ₹102.29 Crores.

- Principal amount remaining unpaid to Micro, Small and Medium Enterprises was ₹32.00 Crores as of March 31, 2026 (FY25: ₹49.51 Crores).

- Lease liabilities increased to ₹47.04 Crores as of March 31, 2026 (FY25: ₹30.86 Crores).

- The consolidated financial statements show Total Assets of ₹8,680.68 Crores and Total Equity of ₹5,869.28 Crores as of March 31, 2026.

- Key subsidiaries include Deepak Phenolics Limited (Revenue: ₹5,374.50 Crores, PAT: ₹539.82 Crores) and Deepak Chem Tech Limited (Revenue: ₹172.23 Crores, Loss after Tax: ₹103.87 Crores).

- The auditor's report provides an unmodified opinion, stating the consolidated financial statements give a true and fair view.

- Revenue from Operations for the year ended March 31, 2026, was ₹ 7,887.07 crores, compared to ₹ 8,281.93 crores in the previous year.

- Total Income for the year was ₹ 7,946.94 crores, down from ₹ 8,365.79 crores in the prior year.

- Profit Before Tax (PBT) stood at ₹ 757.09 crores, a decrease from ₹ 952.75 crores in the previous year.

- Profit for the Year (Net Profit) was ₹ 550.66 crores, down from ₹ 697.37 crores in the prior year.

- Basic and Diluted Earnings Per Share (EPS) were ₹ 40.36, compared to ₹ 51.12 in the previous year.

- Total Comprehensive Income for the year was ₹ 546.91 crores, compared to ₹ 694.06 crores in the prior year.

- The Group paid a dividend of ₹ 102.29 crores on Equity Shares during the year.

- Net Cash Inflow from Operating Activities was ₹ 538.95 crores, a decrease from ₹ 624.70 crores in the previous year.

- Significant capital expenditure was undertaken, with Purchase of Property, Plant and Equipment, including Capital Work-in-Progress, amounting to ₹ 1,184.66 crores.

- Cash and Cash Equivalents at the end of the financial year stood at ₹ 243.14 crores, up from ₹ 179.41 crores at the beginning of the year.

- Financial year ended March 31, 2026.

- Property, Plant and Equipment (PPE) gross carrying amount increased to ₹ 4,509.00 Crores as at March 31, 2026 from ₹ 3,486.27 Crores as at March 31, 2025.

- Capital Work-in-Progress (CWIP) gross carrying amount increased to ₹ 1,828.19 Crores as at March 31, 2026 from ₹ 1,649.05 Crores as at March 31, 2025.

- Intangible Assets gross carrying amount increased to ₹ 108.65 Crores as at March 31, 2026 from ₹ 95.56 Crores as at March 31, 2025.

- Non-Current Investments increased to ₹ 18.15 Crores as at March 31, 2026 from ₹ 2.98 Crores as at March 31, 2025. Includes new investments in FPEL Mercury Private Limited (₹ 3.27 Crores), Amplus Kaveri Solar Private Limited (₹ 1.81 Crores), Greenwin Energy Two LLP (₹ 0.23 Crores), and ASETS-CA Inc (₹ 9.37 Crores).

- Deferred Tax Asset (Net) increased to ₹ 27.33 Crores as at March 31, 2026 from ₹ 11.65 Crores as at March 31, 2025.

- Inventories decreased to ₹ 862.3 Crores as at March 31, 2026 from ₹ 926.4 Crores as at March 31, 2025.

- Current Investments changed to ₹ 195.13 Crores (Mutual Funds) as at March 31, 2026 from ₹ 507.91 Crores (₹ 112.68 Crores in Mutual Funds and ₹ 395.23 Crores in Commercial Paper) as at March 31, 2025.

- Trade Receivables increased to ₹ 1,505.56 Crores (net of allowance) as at March 31, 2026 from ₹ 1,273.81 Crores as at March 31, 2025.

- Cash and Cash Equivalents increased to ₹ 243.14 Crores as at March 31, 2026 from ₹ 179.41 Crores as at March 31, 2025.

- Other Current Financial Assets include Incentive Receivable of ₹ 51.52 Crores (new in FY26).

- Equity Share Capital remains unchanged at ₹ 27.28 Crores (13,63,93,041 shares of ₹ 2 each).

- Other Equity (Reserves & Surplus) increased to ₹ 5,809.55 Crores as at March 31, 2026 from ₹ 5,361.39 Crores as at March 31, 2025.

- Retained Earnings increased to ₹ 5,278.10 Crores as at March 31, 2026 from ₹ 4,827.13 Crores as at March 31, 2025, after adding Profit for the year of ₹ 550.53 Crores and paying Dividend of ₹ 102.29 Crores.

- The Group has two primary reporting segments: Advanced Intermediates and Phenolics.

- Total Revenue from Operations for FY26 was ₹ 7,887.07 Crores, down from ₹ 8,281.93 Crores in FY25.

- Sale of Products contributed ₹ 7,761.25 Crores to revenue in FY26.

- Other Income for FY26 was ₹ 59.87 Crores, a decrease from ₹ 83.86 Crores in FY25.

- Cost of Raw Materials and Components consumed was ₹ 5,324.47 Crores in FY26.

- Employee Benefits Expense increased to ₹ 423.18 Crores in FY26 from ₹ 392.15 Crores.

- Finance Costs rose significantly to ₹ 46.02 Crores in FY26 from ₹ 27.5 Crores.

- Depreciation and Amortisation Expenses increased to ₹ 224.64 Crores in FY26.

- Total Equity stood at ₹ 5,869.28 Crores as of March 31, 2026.

- Total Borrowings increased to ₹ 1,527.82 Crores (20.65% of Total Capital) in FY26 from ₹ 1,170.53 Crores.

- Non-Current Borrowings (Term Loans) were ₹ 1,134.83 Crores, secured against project assets of a subsidiary.

- Current Borrowings increased sharply to ₹ 392.99 Crores, including new unsecured Supplier Financing of ₹ 257.08 Crores.

- Trade Payables were ₹ 534.11 Crores as of March 31, 2026.

- Provision for Employee Benefit Obligations (Gratuity & Leave) totaled ₹ 75.07 Crores (Current ₹ 24.89 Crores + Non-Current ₹ 50.18 Crores).

- Deferred Tax Liabilities (Net) were ₹ 246.73 Crores as of March 31, 2026.

- Capital Commitments (Net of Advances) stood at ₹ 686.17 Crores.

- The Interest Coverage Ratio declined to 25.35 in FY26 from 46.77 in FY25.

- Key Management Personnel include Dr. (Hon.) Deepak Mehta (Chairman & MD), Shri Maulik Mehta (ED & CEO), and Shri Sanjay Upadhyay (Director Finance & Group CFO).